(Q34547415)

English

A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

based on heuristic

inferred from title

randomized controlled trial

1 reference

based on heuristic

inferred from title

author name string

Tien-Tsai Cheng

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Han-Ming Lai

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Chun-Kai Chiu

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Ying-Chou Chem

4

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Clinical Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

26

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

399-406

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

A literature review of the epidemiology and treatment of acute gout

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990035-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind comparison of the analgesic efficacy of intramuscular ketorolac and oral indomethacin in the treatment of acute gouty arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990035-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of parenteral adrenocorticotropic hormone with oral indomethacin in the treatment of acute gout

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990035-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Further experience with indomethacin in the treatment of rheumatic disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990035-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the analgesic efficacy of rofecoxib and enteric-coated diclofenac sodium in the treatment of postoperative dental pain: a randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990035-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990035-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990035-5

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990035-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and tolerability of intramuscular and oral meloxicam in patients with acute lumbago: a comparison with intramuscular and oral piroxicam

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990035-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990035-5

7 January 2021

based on heuristic

inferred from DOI database lookup

A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990035-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0149-2918(04)90035-5

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34547415&oldid=1602999781"